###begin article-title 0
Acidic preconditioning protects endothelial cells against apoptosis through p38- and Akt-dependent Bcl-xL overexpression
###end article-title 0
###begin p 1
###xml 167 170 <span type="species:ncbi:10116">rat</span>
To analyze the underlying cellular mechanisms of adaptation to ischemia-induced apoptosis through short acidic pretreatment, i.e. acidic preconditioning (APC), Wistar rat coronary endothelial cells (EC) were exposed for 40 min to acidosis (pH 6.4) followed by a 14 h recovery period (pH 7.4) and finally treated for 2 h with simulated in vitro ischemia (glucose-free anoxia at pH 6.4). APC led to a transient activation of p38 and Akt kinases, but not of JNK and ERK1/2 kinases, which was accompanied by significant reduction of the apoptotic cell number, caspase-12/-3 cleavage and Bcl-xL overexpression. These effects of APC were completely abolished by prevention of Akt- or p38-phosphorylation during APC. Furthermore, knock-down of Bcl-xL by siRNA-transfection also abolished the anti-apoptotic effect of APC. Therefore, APC leads to protection of EC against ischemic apoptosis by activation of Akt and p38 followed by overexpression of Bcl-xL, which is a key anti-apoptotic mechanism of APC.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
Apoptosis of endothelial cells (EC) may be responsible for acute and chronic coronary artery diseases, e.g. through endothelial dysfunction [1], atherogenesis [2] or thrombosis [3]. Myocardial ischemia has been shown to be an important trigger of apoptosis [4, 5]. Among several protection strategies directed against ischemic injury, ischemic preconditioning, i.e. adaptation to ischemia through one or more short preceding ischemic episodes, demonstrated a powerful protective potential against ischemic cell death [6]. Since pretreatment with ischemia is clinically not applicable, many attempts have been undertaken to achieve the protective effect of ischemic preconditioning either pharmacologically [7] or by pretreatment with moderate environmental stress, e.g. hypoxia [8], glucose deprivation [9] or acidosis [10, 11], which are components of ischemia.
###end p 4
###begin p 5
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
Previously acidosis was found to be an important stress factor triggering apoptosis in coronary EC under ischemic conditions through activation of caspase-12 [12]. Accordingly, short acidic pretreatment, i.e. acidic preconditioning (APC), can protect EC against ischemic apoptosis [11]. The underlying initial cellular mechanism leading to this protection, however, remained unknown. Several previous reports suggested that acidosis may lead to activation of MAP-kinases and PI3-Akt-kinases pathways [13, 14], which play an essential role in regulation of apoptosis [15]. To examine whether these kinases may be responsible for the anti-apoptotic effect of APC was the aim of the present study. We found that APC-induced activation of p38- and Akt-kinases leads to overexpression of Bcl-xL and protection against apoptosis.
###end p 5
###begin title 6
Methods
###end title 6
###begin p 7
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
###end p 7
###begin title 8
Cell culture
###end title 8
###begin p 9
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 49 60 <span type="species:ncbi:10116">Wistar rats</span>
###xml 144 148 <span type="species:ncbi:9913">calf</span>
###xml 171 175 <span type="species:ncbi:9913">calf</span>
Coronary EC were isolated from 250 to 300 g male Wistar rats and maintained in Earle's minimal essential medium 199 supplemented with 10% fetal calf serum and 10% newborn calf serum till two passages as previously described [16]. The purity of the cell culture (>95% EC) was confirmed by immunochemical staining with antibodies against vWF and by uptake of DiI-ac-LDL as previously described [17]. Experiments were performed with monolayers reaching 80-90% confluence and 18 h prior to experiments serum content in culture medium was reduced from 20 to 5%.
###end p 9
###begin title 10
In vitro simulated ischemia
###end title 10
###begin p 11
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 272 273 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 281 282 275 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
To simulate ischemic conditions cells were treated with anoxia in combination with glucose-deprivation and acidosis as described previously [12]. Dishes were incubated for 2 h at 37degreesC in a gas-tight chamber under continuous flush with a humidified gas mixture (95% N2 + 5% CO2). Analysis of the buffer pH after 2 h of simulated ischemia did not reveal any significant alteration.
###end p 11
###begin title 12
Acidic preconditioning
###end title 12
###begin p 13
Before simulated ischemia, cells were exposed to acidosis in cell culture medium (pH 6.4) for 40 min followed by a recovery period for 14 h in cell culture medium at pH 7.4. This protocol of preconditioning with acidosis was chosen from several preconditioning protocols, i.e. variation in time of APC (20-40 min) and in time of recovery period (6-24 h) as well as comparison of single versus repetitive (2 and 3 periods) acidic pretreatment, since it provides the maximal protection against ischemic apoptosis. In control group, similar treatment, i.e. change of medium, was performed at pH 7.4. In some experiments treatment with inhibitors of p38 kinase (SB203580, Calbiochem) and PI3 kinase (LY294002, Calbiochem) during APC was performed.
###end p 13
###begin title 14
Hoechst-33342 and propidium iodide staining
###end title 14
###begin p 15
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
To distinguish between apoptotic and necrotic cells a staining of nuclei with Hoechst-33342 and propidium iodide was applied as described previously [12]. Briefly, cells were trypsinized, washed with PBS and incubated for 10 min with 1 mug/ml Hoechst-33342 and 5 mug/ml propidium iodide. Stained nuclei were visualized with a converted fluorescence microscope at a magnification of 700x using excitation light at 350 nm for Hoechst-33342 and 540 nm for propidium iodide.
###end p 15
###begin p 16
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
For quantitative assay, a blind analysis of 200-300 nuclei from randomized 4-5 fields was applied. Cells were scored as apoptotic, when nuclei stained with Hoechst-33342 produced unequivocal bright blue fluorescence due to chromatin condensation [12]. Propidium iodide stained nuclei with normal nuclear morphology, i.e. without signs of chromatin condensation, were scored as necrotic. Cells exhibiting both chromatin alteration and propidium iodide stained nuclei (i.e. "late-stage apoptotic cells") were included in the apoptotic population. The number of these cells did not exceed 5% of all cells.
###end p 16
###begin title 17
TUNEL staining
###end title 17
###begin p 18
TUNEL staining using the In Situ Cell Death Detection Kit, TMR red (Roche Diagnostic GmbH, Mannheim) was performed according to the manufacturer's instruction. Samples were analyzed with a Leica TCS SP2 confocal microscope. Four culture dishes (each 200-300 cells) per group were used for the quantification of TUNEL positive cells.
###end p 18
###begin title 19
Western blot
###end title 19
###begin p 20
Primary antibodies were: phospho-ERK1/2, ERK1/2, phospho-SAPK/JNK, SAPK/JNK phospho-Akt, Akt, phospho-p38, p38, Bcl-xL and caspase-3 (Cell Signaling), phospho-p38alpha (Millipore), p38beta (Santa Cruz), actin (Chemicon International), and caspase-12 (Calbiochem). Specific bands were visualized after incubation with peroxidase-linked/HRP-labeled secondary antibodies by chemiluminescence using Super-Signal kit (Thermo Scientific). For multiple analyses of different proteins, western blot was performed from the same cell extract. Equivalent sample loading (60 mug proteins/well) was confirmed by stripping membranes with the Blot Restore Membrane Stripping buffer (Thermo Scientific) followed by treatment with antibodies against actin. Since the loading control was similar in all membranes, only one blot was shown in representative figures.
###end p 20
###begin title 21
siRNA transfection
###end title 21
###begin p 22
###xml 143 146 <span type="species:ncbi:10116">rat</span>
###xml 199 202 <span type="species:ncbi:9685">Cat</span>
###xml 306 309 <span type="species:ncbi:9685">Cat</span>
###xml 488 494 <span type="species:ncbi:9913">bovine</span>
Knock-down of Bcl-xL was achieved by treatment of EC with small interfering RNA (siRNA) duplexes, corresponding to separate regions within the rat Bcl-xL RNA sequence (Accession number NM_001033671, Cat. Nr: L-080091-01, Dharmacon Research, Lafayette, CO, USA). As a control, non-targeting siRNA duplexes (Cat. Nr: D-001810-01) were applied. Cells were transfected according to manufacturer's instructions. Briefly, cells were seeded 1 day before transfection in MEM containing 10% fetal bovine serum without antibiotics. Bcl-xL siRNA or non-targeting siRNA were mixed with oligofectamine (Invitrogen) in OptiMEM (Gibco BRL) for 15 min at room temperature and then added to the culture medium at a final concentration of 60 nM. Cells were incubated at 37degreesC for 72 h. Protein expression was determined by Western blot using a specific antibody to Bcl-xL, which revealed >/=90% reduction of Bcl-xL after 72 h.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 202 203 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are given as mean +/- SEM. The comparison of means between the groups was performed by one-way analysis of variance followed by Bonferroni post-hoc test. Statistical significance was accepted when P < 0.05.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
APC-induced protection is accompanied by phosphorylation of p38 and Akt kinases
###end title 26
###begin p 27
###xml 125 126 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 138 139 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 319 320 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 326 327 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 743 744 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 856 857 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 991 997 987 993 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1069 1070 1065 1066 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1242 1244 1238 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 1302 1303 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1312 1313 1306 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1332 1333 1326 1327 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1489 1492 1483 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 1626 1627 1620 1621 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1723 1724 1717 1718 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1797 1800 1791 1794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 1832 1833 1826 1827 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1899 1901 1893 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CM</italic>
###xml 997 2087 993 2081 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">APC suppressed apoptosis and induced activation of p38 and Akt kinases. <bold>a</bold> Number of apoptotic EC (Hoechst-33342 staining) and western blot analysis of cleaved caspase-3 under control conditions (no treatment) or after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;5&#8211;6. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI. <bold>b</bold> Western blot analysis of phospho-ERK1/2, phospho-SAPK/JNK, phospho-p38 and phospho-Akt kinases performed with whole cell lysates prepared from control EC (<italic>Con</italic>) or from EC after 10&#160;min of APC. APC led to a marked increase in phosphorylation of Akt and p38, but not ERK1/2 or SAPK/JNK kinases. <bold>c</bold> Western blot analysis of phospho-p38 and phospho-Akt at different time (10&#8211;40&#160;min) during APC. <bold>d</bold> Western blot analysis of p38-alpha and phospho-p38-alpha in control EC (<italic>Con</italic>) or in EC after 10&#160;min of APC. <bold>e</bold> Western blot analysis of p38-beta in control rat cardiomyocytes (<italic>CM</italic>) or in control rat coronary EC. Note that no p38-beta protein could be detected in EC. Western blot data are representative of three to five independent experiments with similar results</p>
###xml 997 2087 993 2081 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">APC suppressed apoptosis and induced activation of p38 and Akt kinases. <bold>a</bold> Number of apoptotic EC (Hoechst-33342 staining) and western blot analysis of cleaved caspase-3 under control conditions (no treatment) or after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;5&#8211;6. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI. <bold>b</bold> Western blot analysis of phospho-ERK1/2, phospho-SAPK/JNK, phospho-p38 and phospho-Akt kinases performed with whole cell lysates prepared from control EC (<italic>Con</italic>) or from EC after 10&#160;min of APC. APC led to a marked increase in phosphorylation of Akt and p38, but not ERK1/2 or SAPK/JNK kinases. <bold>c</bold> Western blot analysis of phospho-p38 and phospho-Akt at different time (10&#8211;40&#160;min) during APC. <bold>d</bold> Western blot analysis of p38-alpha and phospho-p38-alpha in control EC (<italic>Con</italic>) or in EC after 10&#160;min of APC. <bold>e</bold> Western blot analysis of p38-beta in control rat cardiomyocytes (<italic>CM</italic>) or in control rat coronary EC. Note that no p38-beta protein could be detected in EC. Western blot data are representative of three to five independent experiments with similar results</p></caption>
###xml 2087 2087 2081 2081 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10495_2008_287_Fig1_HTML" id="MO1"/>
###xml 991 2087 987 2081 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="28">APC suppressed apoptosis and induced activation of p38 and Akt kinases. <bold>a</bold> Number of apoptotic EC (Hoechst-33342 staining) and western blot analysis of cleaved caspase-3 under control conditions (no treatment) or after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;5&#8211;6. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI. <bold>b</bold> Western blot analysis of phospho-ERK1/2, phospho-SAPK/JNK, phospho-p38 and phospho-Akt kinases performed with whole cell lysates prepared from control EC (<italic>Con</italic>) or from EC after 10&#160;min of APC. APC led to a marked increase in phosphorylation of Akt and p38, but not ERK1/2 or SAPK/JNK kinases. <bold>c</bold> Western blot analysis of phospho-p38 and phospho-Akt at different time (10&#8211;40&#160;min) during APC. <bold>d</bold> Western blot analysis of p38-alpha and phospho-p38-alpha in control EC (<italic>Con</italic>) or in EC after 10&#160;min of APC. <bold>e</bold> Western blot analysis of p38-beta in control rat cardiomyocytes (<italic>CM</italic>) or in control rat coronary EC. Note that no p38-beta protein could be detected in EC. Western blot data are representative of three to five independent experiments with similar results</p></caption><graphic position="anchor" xlink:href="10495_2008_287_Fig1_HTML" id="MO1"/></fig>
###xml 1879 1882 <span type="species:ncbi:10116">rat</span>
###xml 1917 1920 <span type="species:ncbi:10116">rat</span>
Exposure of EC to simulated ischemia for 2 h led to cleavage of caspase-3 and a rise of apoptotic cell number (28.8 +/- 1.4, n = 5) (Fig. 1a). Short pretreatment with acidosis (pH 6.4) in the cell culture medium followed by a recovery period at pH 7.4, i.e. APC, significantly reduced the apoptosis rate (13.0 +/- 1.1, n = 6, P < 0.05 vs. ischemia alone) and caspase-3 cleavage. To examine whether this effect is due to activation of Akt or MAP kinases, phosphorylation of Akt, p38, ERK1/2 and JNK kinases was analyzed. Acidic treatment in cell culture medium did not increase the phosphorylation of ERK1/2 and JNK kinases, whereas the phosphorylation of p38 kinase and Akt kinase was markedly increased after 10 min of acidic treatment (Fig. 1b). This effect was transient and nearly disappeared at the end of acidic pretreatment, i.e. after 40 min (Fig. 1c). Change of medium pH from 6.4 to 7.4 after 40 min of APC had no effect on phosphorylation of investigated kinases (data not shown).Fig. 1APC suppressed apoptosis and induced activation of p38 and Akt kinases. a Number of apoptotic EC (Hoechst-33342 staining) and western blot analysis of cleaved caspase-3 under control conditions (no treatment) or after 2 h of simulated ischemia (SI) without or with APC treatment. Values are mean +/- SEM, n = 5-6. *P < 0.05 versus SI. b Western blot analysis of phospho-ERK1/2, phospho-SAPK/JNK, phospho-p38 and phospho-Akt kinases performed with whole cell lysates prepared from control EC (Con) or from EC after 10 min of APC. APC led to a marked increase in phosphorylation of Akt and p38, but not ERK1/2 or SAPK/JNK kinases. c Western blot analysis of phospho-p38 and phospho-Akt at different time (10-40 min) during APC. d Western blot analysis of p38-alpha and phospho-p38-alpha in control EC (Con) or in EC after 10 min of APC. e Western blot analysis of p38-beta in control rat cardiomyocytes (CM) or in control rat coronary EC. Note that no p38-beta protein could be detected in EC. Western blot data are representative of three to five independent experiments with similar results
###end p 27
###begin p 28
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 245 247 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 305 306 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 315 316 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 335 336 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 492 495 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 629 630 627 628 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 726 727 724 725 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 800 803 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 835 836 833 834 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 902 904 900 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CM</italic>
###xml 882 885 <span type="species:ncbi:10116">rat</span>
###xml 920 923 <span type="species:ncbi:10116">rat</span>
APC suppressed apoptosis and induced activation of p38 and Akt kinases. a Number of apoptotic EC (Hoechst-33342 staining) and western blot analysis of cleaved caspase-3 under control conditions (no treatment) or after 2 h of simulated ischemia (SI) without or with APC treatment. Values are mean +/- SEM, n = 5-6. *P < 0.05 versus SI. b Western blot analysis of phospho-ERK1/2, phospho-SAPK/JNK, phospho-p38 and phospho-Akt kinases performed with whole cell lysates prepared from control EC (Con) or from EC after 10 min of APC. APC led to a marked increase in phosphorylation of Akt and p38, but not ERK1/2 or SAPK/JNK kinases. c Western blot analysis of phospho-p38 and phospho-Akt at different time (10-40 min) during APC. d Western blot analysis of p38-alpha and phospho-p38-alpha in control EC (Con) or in EC after 10 min of APC. e Western blot analysis of p38-beta in control rat cardiomyocytes (CM) or in control rat coronary EC. Note that no p38-beta protein could be detected in EC. Western blot data are representative of three to five independent experiments with similar results
###end p 28
###begin p 29
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 415 418 <span type="species:ncbi:10116">rat</span>
###xml 443 446 <span type="species:ncbi:10116">rat</span>
It has been shown that two isoforms of p38 kinase, i.e. p38-alpha and p38-beta, are expressed in the myocardium [18]. Therefore, to find out which isoform was activated by APC western blot analysis was performed. A marked expression of p38-alpha was found in EC (Fig. 1d). APC significantly increased the phosphorylation of p38-alpha. Surprisingly, no p38-beta expression could be found by western blot analysis in rat coronary EC, whereas in rat ventricular cardiomyocytes, used as a positive control, a marked expression p38-beta was found (Fig. 1e).
###end p 29
###begin title 30
Inhibition of p38 and Akt kinases activation abolishes the anti-apoptotic effect of APC
###end title 30
###begin p 31
###xml 441 442 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 619 621 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 623 629 621 627 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 706 707 704 705 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 748 750 746 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 781 783 779 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 1011 1012 1009 1010 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1178 1180 1176 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 1263 1265 1260 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 1307 1309 1303 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 1391 1392 1385 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1401 1402 1395 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1421 1422 1415 1416 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1523 1525 1517 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 1604 1609 1598 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1641 1645 1635 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1648 1654 1642 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 1687 1688 1681 1682 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1781 1782 1775 1776 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1809 1810 1801 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1817 1818 1809 1810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 629 1835 627 1827 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">Inhibition of p38 or Akt kinases prevented the anti-apoptotic effect of APC. <bold>a</bold> Inhibition of p38 kinase with SB203580 (<italic>SB</italic>) or PI3 kinase with LY294002 (<italic>LY</italic>) during APC abolished the APC-induced phosphorylation of p38 and Akt kinases without significant cross-effect on Akt and p38 kinases, respectively. Data are representative of three independent experiments with similar results. <bold>b</bold> Number of apoptotic (Hoechst-33342 staining) and necrotic EC (propidium iodide staining) under control conditions (no treatment) or after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. Inhibition of p38 kinase with 3&#160;&#956;mol/l SB203580 (<italic>SB</italic>) or PI3 kinase with 10&#160;&#956;mol/l LY294002 (<italic>LY</italic>) during APC abolished the anti-apoptotic effect of APC. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;6&#8211;8. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI. <bold>c</bold> Representative images of the TUNEL-staining in control EC or in EC after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. F-actin was stained with specific antibodies (<italic>green</italic>) and nuclei were stained DAPI (<italic>blue</italic>). <italic>Arrows</italic> show nuclei of apoptotic cells. <bold>d</bold> Statistical analysis of the number of TUNEL-positive apoptotic EC. Similar conditions as in <bold>b</bold>. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;4. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI</p>
###xml 629 1835 627 1827 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">Inhibition of p38 or Akt kinases prevented the anti-apoptotic effect of APC. <bold>a</bold> Inhibition of p38 kinase with SB203580 (<italic>SB</italic>) or PI3 kinase with LY294002 (<italic>LY</italic>) during APC abolished the APC-induced phosphorylation of p38 and Akt kinases without significant cross-effect on Akt and p38 kinases, respectively. Data are representative of three independent experiments with similar results. <bold>b</bold> Number of apoptotic (Hoechst-33342 staining) and necrotic EC (propidium iodide staining) under control conditions (no treatment) or after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. Inhibition of p38 kinase with 3&#160;&#956;mol/l SB203580 (<italic>SB</italic>) or PI3 kinase with 10&#160;&#956;mol/l LY294002 (<italic>LY</italic>) during APC abolished the anti-apoptotic effect of APC. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;6&#8211;8. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI. <bold>c</bold> Representative images of the TUNEL-staining in control EC or in EC after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. F-actin was stained with specific antibodies (<italic>green</italic>) and nuclei were stained DAPI (<italic>blue</italic>). <italic>Arrows</italic> show nuclei of apoptotic cells. <bold>d</bold> Statistical analysis of the number of TUNEL-positive apoptotic EC. Similar conditions as in <bold>b</bold>. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;4. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI</p></caption>
###xml 1835 1835 1827 1827 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10495_2008_287_Fig2_HTML" id="MO2"/>
###xml 623 1835 621 1827 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="32">Inhibition of p38 or Akt kinases prevented the anti-apoptotic effect of APC. <bold>a</bold> Inhibition of p38 kinase with SB203580 (<italic>SB</italic>) or PI3 kinase with LY294002 (<italic>LY</italic>) during APC abolished the APC-induced phosphorylation of p38 and Akt kinases without significant cross-effect on Akt and p38 kinases, respectively. Data are representative of three independent experiments with similar results. <bold>b</bold> Number of apoptotic (Hoechst-33342 staining) and necrotic EC (propidium iodide staining) under control conditions (no treatment) or after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. Inhibition of p38 kinase with 3&#160;&#956;mol/l SB203580 (<italic>SB</italic>) or PI3 kinase with 10&#160;&#956;mol/l LY294002 (<italic>LY</italic>) during APC abolished the anti-apoptotic effect of APC. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;6&#8211;8. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI. <bold>c</bold> Representative images of the TUNEL-staining in control EC or in EC after 2&#160;h of simulated ischemia (<italic>SI</italic>) without or with APC treatment. F-actin was stained with specific antibodies (<italic>green</italic>) and nuclei were stained DAPI (<italic>blue</italic>). <italic>Arrows</italic> show nuclei of apoptotic cells. <bold>d</bold> Statistical analysis of the number of TUNEL-positive apoptotic EC. Similar conditions as in <bold>b</bold>. Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;4. *<italic>P</italic>&#160;&lt;&#160;0.05 versus SI</p></caption><graphic position="anchor" xlink:href="10495_2008_287_Fig2_HTML" id="MO2"/></fig>
To find out whether activation of p38 and Akt kinases during APC plays a causal role in the anti-apoptotic effect of preconditioning, treatment with 3 mumol/l SB203580, a specific inhibitor of p38 kinase, or with 10 mumol/l LY294002, a specific inhibitor of PI3 kinase, was applied during APC. These concentrations were used as they abolished kinases phosphorylation without cross-reaction on Akt and p38 phosphorylation, respectively (Fig. 2a). The finding that treatment with SB203580 prevented acidosis-induced p38 phosphorylation indicates the involvement of the acidosis-induced autophosphorylation of p38 kinase [19].Fig. 2Inhibition of p38 or Akt kinases prevented the anti-apoptotic effect of APC. a Inhibition of p38 kinase with SB203580 (SB) or PI3 kinase with LY294002 (LY) during APC abolished the APC-induced phosphorylation of p38 and Akt kinases without significant cross-effect on Akt and p38 kinases, respectively. Data are representative of three independent experiments with similar results. b Number of apoptotic (Hoechst-33342 staining) and necrotic EC (propidium iodide staining) under control conditions (no treatment) or after 2 h of simulated ischemia (SI) without or with APC treatment. Inhibition of p38 kinase with 3 mumol/l SB203580 (SB) or PI3 kinase with 10 mumol/l LY294002 (LY) during APC abolished the anti-apoptotic effect of APC. Values are mean +/- SEM, n = 6-8. *P < 0.05 versus SI. c Representative images of the TUNEL-staining in control EC or in EC after 2 h of simulated ischemia (SI) without or with APC treatment. F-actin was stained with specific antibodies (green) and nuclei were stained DAPI (blue). Arrows show nuclei of apoptotic cells. d Statistical analysis of the number of TUNEL-positive apoptotic EC. Similar conditions as in b. Values are mean +/- SEM, n = 4. *P < 0.05 versus SI
###end p 31
###begin p 32
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 119 121 119 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 152 154 152 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 382 383 382 383 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 549 551 549 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 634 636 633 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 678 680 676 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 762 763 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 772 773 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 792 793 788 789 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 894 896 890 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 975 980 971 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1012 1016 1008 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1019 1025 1015 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 1058 1059 1054 1055 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1152 1153 1148 1149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1180 1181 1174 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1188 1189 1182 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Inhibition of p38 or Akt kinases prevented the anti-apoptotic effect of APC. a Inhibition of p38 kinase with SB203580 (SB) or PI3 kinase with LY294002 (LY) during APC abolished the APC-induced phosphorylation of p38 and Akt kinases without significant cross-effect on Akt and p38 kinases, respectively. Data are representative of three independent experiments with similar results. b Number of apoptotic (Hoechst-33342 staining) and necrotic EC (propidium iodide staining) under control conditions (no treatment) or after 2 h of simulated ischemia (SI) without or with APC treatment. Inhibition of p38 kinase with 3 mumol/l SB203580 (SB) or PI3 kinase with 10 mumol/l LY294002 (LY) during APC abolished the anti-apoptotic effect of APC. Values are mean +/- SEM, n = 6-8. *P < 0.05 versus SI. c Representative images of the TUNEL-staining in control EC or in EC after 2 h of simulated ischemia (SI) without or with APC treatment. F-actin was stained with specific antibodies (green) and nuclei were stained DAPI (blue). Arrows show nuclei of apoptotic cells. d Statistical analysis of the number of TUNEL-positive apoptotic EC. Similar conditions as in b. Values are mean +/- SEM, n = 4. *P < 0.05 versus SI
###end p 32
###begin p 33
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
Analysis of apoptotic cell number revealed, that inhibition of p38 or Akt kinases activation during acidic pretreatment abolished the anti-apoptotic effect of APC, i.e. reduction of the apoptotic cell number (Hoechst-33342 staining), whereas treatment with inhibitors alone, i.e. without APC, had no effects on ischemia-induced apoptosis. No effect on necrotic cell death could be detected (Fig. 2b). Similarly, APC alone had no effects on apoptotic or necrotic cell death during 14 h recovery period in our model [11].
###end p 33
###begin p 34
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
To substantiate the apoptosis analysis, TUNEL staining of the nuclei was performed (Fig. 2c). This apoptosis detection method confirmed our data with Hoechst-33342 staining and demonstrated prevention of the anti-apoptotic effect of APC by inhibition of p38 and Akt kinases (Fig. 2d).
###end p 34
###begin p 35
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 460 466 460 466 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 590 592 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 670 672 669 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 703 705 701 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 466 868 466 866 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">Western blot analysis of cleaved caspase-12 prepared from extracts of control EC (<italic>Con</italic>) or EC exposed to simulated ischemia (<italic>SI</italic>) without or with APC treatment. Note that treatment with 3&#160;&#956;mol/l SB203580 (<italic>SB</italic>) or with 10&#160;&#956;mol/l LY294002 (<italic>LY</italic>) during APC abolished the inhibitory effect of APC on caspase-12 cleavage during SI. Data are representative of three independent experiments with similar results</p>
###xml 466 868 466 866 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36">Western blot analysis of cleaved caspase-12 prepared from extracts of control EC (<italic>Con</italic>) or EC exposed to simulated ischemia (<italic>SI</italic>) without or with APC treatment. Note that treatment with 3&#160;&#956;mol/l SB203580 (<italic>SB</italic>) or with 10&#160;&#956;mol/l LY294002 (<italic>LY</italic>) during APC abolished the inhibitory effect of APC on caspase-12 cleavage during SI. Data are representative of three independent experiments with similar results</p></caption>
###xml 868 868 866 866 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10495_2008_287_Fig3_HTML" id="MO3"/>
###xml 460 868 460 866 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="36">Western blot analysis of cleaved caspase-12 prepared from extracts of control EC (<italic>Con</italic>) or EC exposed to simulated ischemia (<italic>SI</italic>) without or with APC treatment. Note that treatment with 3&#160;&#956;mol/l SB203580 (<italic>SB</italic>) or with 10&#160;&#956;mol/l LY294002 (<italic>LY</italic>) during APC abolished the inhibitory effect of APC on caspase-12 cleavage during SI. Data are representative of three independent experiments with similar results</p></caption><graphic position="anchor" xlink:href="10495_2008_287_Fig3_HTML" id="MO3"/></fig>
It has been shown that exposure of coronary EC to simulated ischemia leads to apoptosis mainly through activation of ER dependent pathway, i.e. due to cleavage of ER-bound caspase-12 [12]. Similarly, in the present study a cleavage of caspase-12 was found (Fig. 3), which was attenuated by APC. This effect of APC was p38- and Akt-dependent, since inhibition of these kinases during acidic pretreatment abolished the APC-effect on caspase-12 cleavage (Fig. 3).Fig. 3Western blot analysis of cleaved caspase-12 prepared from extracts of control EC (Con) or EC exposed to simulated ischemia (SI) without or with APC treatment. Note that treatment with 3 mumol/l SB203580 (SB) or with 10 mumol/l LY294002 (LY) during APC abolished the inhibitory effect of APC on caspase-12 cleavage during SI. Data are representative of three independent experiments with similar results
###end p 35
###begin p 36
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 124 126 124 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 204 206 203 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 237 239 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
Western blot analysis of cleaved caspase-12 prepared from extracts of control EC (Con) or EC exposed to simulated ischemia (SI) without or with APC treatment. Note that treatment with 3 mumol/l SB203580 (SB) or with 10 mumol/l LY294002 (LY) during APC abolished the inhibitory effect of APC on caspase-12 cleavage during SI. Data are representative of three independent experiments with similar results
###end p 36
###begin title 37
Acidic preconditioning-induced overexpression of Bcl-xL is p38- and Akt-dependent
###end title 37
###begin p 38
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 535 541 535 541 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 609 610 609 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 681 684 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 743 746 743 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 784 786 784 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 801 803 801 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 936 937 936 937 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1008 1011 1008 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 1168 1169 1168 1169 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1265 1276 1265 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siRNA&#160;+&#160;APC</italic>
###xml 1295 1300 1295 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siRNA</italic>
###xml 1382 1383 1382 1383 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1439 1444 1439 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siRNA</italic>
###xml 1474 1477 1474 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 1542 1544 1542 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 1571 1572 1569 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 541 1680 541 1678 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">Importance of Bcl-xL overexpression in protective mechanism of APC. <bold>a</bold> Western blot analysis of Bcl-xL prepared from extracts of control EC (<italic>Con</italic>) or EC after 40&#160;min APC followed by 14&#160;h recovery period (<italic>APC</italic>). Note that treatment with SB203580 (<italic>SB</italic>) or LY294002 (<italic>LY</italic>) abolished the APC-induced overexpression of Bcl-xL. Data are representative of three independent experiments with similar results. <bold>b</bold> Western blot analysis of Bcl-xL prepared from extracts of control EC (<italic>Con</italic>) or EC after treatment with Bcl-xL targeting siRNA (siRNA, 60&#160;nmol/l, 72&#160;h). Data are representative of three independent experiments with similar results. <bold>c</bold> Western blot analysis of Bcl-xL in EC pre-treated with Bcl-xL targeting siRNA followed by APC (<italic>siRNA&#160;+&#160;APC</italic>) or no treatment (<italic>siRNA</italic>). Data are representative of three independent experiments with similar results. <bold>d</bold> Effect of pre-treatment for 72&#160;h with targeting siRNA (<italic>siRNA</italic>) and acidic preconditioning (<italic>APC</italic>) on the number of apoptotic EC after 2&#160;h of simulated ischemia (<italic>SI</italic>).Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;4&#8211;5. Note that no reduction of the apoptotic cell number by APC could be detected after Bcl-xL knock-down</p>
###xml 541 1680 541 1678 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">Importance of Bcl-xL overexpression in protective mechanism of APC. <bold>a</bold> Western blot analysis of Bcl-xL prepared from extracts of control EC (<italic>Con</italic>) or EC after 40&#160;min APC followed by 14&#160;h recovery period (<italic>APC</italic>). Note that treatment with SB203580 (<italic>SB</italic>) or LY294002 (<italic>LY</italic>) abolished the APC-induced overexpression of Bcl-xL. Data are representative of three independent experiments with similar results. <bold>b</bold> Western blot analysis of Bcl-xL prepared from extracts of control EC (<italic>Con</italic>) or EC after treatment with Bcl-xL targeting siRNA (siRNA, 60&#160;nmol/l, 72&#160;h). Data are representative of three independent experiments with similar results. <bold>c</bold> Western blot analysis of Bcl-xL in EC pre-treated with Bcl-xL targeting siRNA followed by APC (<italic>siRNA&#160;+&#160;APC</italic>) or no treatment (<italic>siRNA</italic>). Data are representative of three independent experiments with similar results. <bold>d</bold> Effect of pre-treatment for 72&#160;h with targeting siRNA (<italic>siRNA</italic>) and acidic preconditioning (<italic>APC</italic>) on the number of apoptotic EC after 2&#160;h of simulated ischemia (<italic>SI</italic>).Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;4&#8211;5. Note that no reduction of the apoptotic cell number by APC could be detected after Bcl-xL knock-down</p></caption>
###xml 1680 1680 1678 1678 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10495_2008_287_Fig4_HTML" id="MO4"/>
###xml 535 1680 535 1678 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="39">Importance of Bcl-xL overexpression in protective mechanism of APC. <bold>a</bold> Western blot analysis of Bcl-xL prepared from extracts of control EC (<italic>Con</italic>) or EC after 40&#160;min APC followed by 14&#160;h recovery period (<italic>APC</italic>). Note that treatment with SB203580 (<italic>SB</italic>) or LY294002 (<italic>LY</italic>) abolished the APC-induced overexpression of Bcl-xL. Data are representative of three independent experiments with similar results. <bold>b</bold> Western blot analysis of Bcl-xL prepared from extracts of control EC (<italic>Con</italic>) or EC after treatment with Bcl-xL targeting siRNA (siRNA, 60&#160;nmol/l, 72&#160;h). Data are representative of three independent experiments with similar results. <bold>c</bold> Western blot analysis of Bcl-xL in EC pre-treated with Bcl-xL targeting siRNA followed by APC (<italic>siRNA&#160;+&#160;APC</italic>) or no treatment (<italic>siRNA</italic>). Data are representative of three independent experiments with similar results. <bold>d</bold> Effect of pre-treatment for 72&#160;h with targeting siRNA (<italic>siRNA</italic>) and acidic preconditioning (<italic>APC</italic>) on the number of apoptotic EC after 2&#160;h of simulated ischemia (<italic>SI</italic>).Values are mean&#160;&#177;&#160;SEM, <italic>n</italic>&#160;=&#160;4&#8211;5. Note that no reduction of the apoptotic cell number by APC could be detected after Bcl-xL knock-down</p></caption><graphic position="anchor" xlink:href="10495_2008_287_Fig4_HTML" id="MO4"/></fig>
To understand more about the underlying downstream anti-apoptotic mechanisms induced by p38 and Akt activation, the expression of Bcl-2 family proteins, i.e. Bax, Bak, Bcl-xL and Bcl-2, was investigated. Although APC did not change the expression of Bax, Bak and Bcl-2 (data not shown), the pronounced over-expression of Bcl-xL was detected by western blot analysis (Fig. 4a). The APC-induced Bcl-xL overexpression was p38- and Akt-dependent, since inhibition of p38 or Akt kinases during APC prevented Bcl-xL overexpression (Fig. 4a).Fig. 4Importance of Bcl-xL overexpression in protective mechanism of APC. a Western blot analysis of Bcl-xL prepared from extracts of control EC (Con) or EC after 40 min APC followed by 14 h recovery period (APC). Note that treatment with SB203580 (SB) or LY294002 (LY) abolished the APC-induced overexpression of Bcl-xL. Data are representative of three independent experiments with similar results. b Western blot analysis of Bcl-xL prepared from extracts of control EC (Con) or EC after treatment with Bcl-xL targeting siRNA (siRNA, 60 nmol/l, 72 h). Data are representative of three independent experiments with similar results. c Western blot analysis of Bcl-xL in EC pre-treated with Bcl-xL targeting siRNA followed by APC (siRNA + APC) or no treatment (siRNA). Data are representative of three independent experiments with similar results. d Effect of pre-treatment for 72 h with targeting siRNA (siRNA) and acidic preconditioning (APC) on the number of apoptotic EC after 2 h of simulated ischemia (SI).Values are mean +/- SEM, n = 4-5. Note that no reduction of the apoptotic cell number by APC could be detected after Bcl-xL knock-down
###end p 38
###begin p 39
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 243 245 243 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB</italic>
###xml 260 262 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 395 396 395 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 627 628 627 628 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 724 735 724 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siRNA&#160;+&#160;APC</italic>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siRNA</italic>
###xml 841 842 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 898 903 898 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siRNA</italic>
###xml 933 936 933 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 1001 1003 1001 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SI</italic>
###xml 1030 1031 1028 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Importance of Bcl-xL overexpression in protective mechanism of APC. a Western blot analysis of Bcl-xL prepared from extracts of control EC (Con) or EC after 40 min APC followed by 14 h recovery period (APC). Note that treatment with SB203580 (SB) or LY294002 (LY) abolished the APC-induced overexpression of Bcl-xL. Data are representative of three independent experiments with similar results. b Western blot analysis of Bcl-xL prepared from extracts of control EC (Con) or EC after treatment with Bcl-xL targeting siRNA (siRNA, 60 nmol/l, 72 h). Data are representative of three independent experiments with similar results. c Western blot analysis of Bcl-xL in EC pre-treated with Bcl-xL targeting siRNA followed by APC (siRNA + APC) or no treatment (siRNA). Data are representative of three independent experiments with similar results. d Effect of pre-treatment for 72 h with targeting siRNA (siRNA) and acidic preconditioning (APC) on the number of apoptotic EC after 2 h of simulated ischemia (SI).Values are mean +/- SEM, n = 4-5. Note that no reduction of the apoptotic cell number by APC could be detected after Bcl-xL knock-down
###end p 39
###begin p 40
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
To prove whether the Akt- and p38-dependent overexpression of Bcl-xL might be a key mechanism in the APC-induced protection against ischemic apoptosis, knock-down of Bcl-xL was performed before simulated ischemia by treatment of EC with Bcl-xL targeting siRNA. After 72 h treatment the reduction of Bcl-xL by about 90% was found (Fig. 4b). Under siRNA pre-treatment, no rise of Bcl-xL expression could be detected after APC (Fig. 4c). Subsequent analysis of apoptosis revealed that the Bcl-xL knock-down abolished the anti-apoptotic effect of APC (Fig. 4d).
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
The aim of the present study was to find out which signaling mechanisms participate in the anti-apoptotic effect of APC. The main findings are the following: (1) The anti-apoptotic effect of APC was associated with transient phosphorylations of p38 and Akt kinases during acidic pretreatment followed by overexpression of Bcl-xL. (2) Prevention of the phosphorylation of these kinases during APC abolished the APC-induced overexpression of Bcl-xL and the anti-apoptotic effect of APC.
###end p 42
###begin p 43
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 1057 1058 1057 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1470 1472 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1474 1476 1474 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1478 1480 1478 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1532 1534 1532 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1716 1718 1716 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 1787 1789 1787 1789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1837 1839 1837 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1696 1699 <span type="species:ncbi:10116">rat</span>
###xml 1768 1773 <span type="species:ncbi:9606">human</span>
###xml 1811 1816 <span type="species:ncbi:9606">human</span>
In the present study we used the model of simulated in vitro ischemia, i.e. combination of glucose-free anoxia with extracellular acidosis (pH 6.4), which was characterized previously in details for endothelial cells and cardiomyocytes [11, 20, 21]. Such an extent of extracellular acidification is comparable to an in vivo myocardial ischemia, where extracellular pH can drop to as low as 6.0 [22]. It has been shown that acidification is an initial trigger for the cleavage and activation of the endoplasmic reticulum-bound caspase-12 and subsequent apoptosis of coronary EC under simulated ischemia [12]. Several reports from other groups confirmed a pro-apoptotic potential of severe acidosis in vitro and in vivo [23-25]. Thus, acidosis seems to be an important stress factor leading to apoptosis under ischemic environment. According to the preconditioning paradigm, "almost any stress factor that is potentially harmful for cells can elicit a preconditioned state, i.e. increased resistance to the damaging stress, when applied in small quantities" [6]. Indeed, protective effect of APC was demonstrated in cell culture [11] and in the whole heart [10]. However, the underlying cellular mechanisms of this protection, specifically against ischemic apoptosis, were poorly understood. In the present study the phosphorylation of several MAP kinases and Akt kinase was investigated, since these kinases (1) can be activated by extra- or intracellular acidification [13, 14, 26] and (2) may modulate the processing of apoptosis [15]. The kinase-pattern activated by acidosis is dependent on the cell type. Indeed, a similar degree of acidosis (pH 6.5-6.6) leads to activation of p38 kinase in rat cardiomyocytes [27], whereas it induces activation of PI3 kinase in human neutrophils [14] or ERK1/2 kinase in human glioblastoma cells [13]. In the present study, applying coronary endothelial cells, a significant increase in phosphorylation of Akt and p38 kinases, but not ERK1/2 or SAPK/JNK kinases, during acidic treatment was found. The activation of these kinases seems to be an initial mechanism in the anti-apoptotic effect of APC, since inhibition of Akt and p38 activation during APC completely abolished the APC-induced protection against ischemic apoptosis.
###end p 43
###begin p 44
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 597 603 597 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-xl</italic>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 934 940 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-xl</italic>
###xml 1163 1164 1163 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
In agreement with these findings, several studies demonstrated the involvement of both p38 and Akt kinases in the protection against apoptosis induced by various protocols of preconditioning [27-29]. The cellular mechanisms of the anti-apoptotic action of Akt and p38 are complex. In the present study we found that the overexpression of Bcl-xL is an important link between Akt-/p38-activation and the protection against apoptosis. In agreement with this finding, the regulation of Bcl-xL expression by Akt and p38 kinases has been previously shown [30, 31]. The transcriptional regulation of the bcl-xl gene involves participation of several transcriptional factors, e.g. STATs, Rel/NF-kB, Ets and AP-1 [32]. Since Akt and p38 kinases are potential up-stream kinases regulating these transcriptional factors, it can be suggested that the acidosis-induced activation of Akt and p38 kinases leads to a transcriptional up-regulation of bcl-xl gene. Bcl-xL overexpression seems to be the key mechanism down-stream of p38 and Akt kinases responsible for the anti-apoptotic effect of APC, since Bcl-xL knock-down completely abolished the APC effect on apoptosis (Fig. 4).
###end p 44
###begin p 45
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
Previously we found that cleavage of the endoplasmic reticulum-bound caspase-12 represents a main apoptotic pathway in coronary EC under simulated ischemia [12]. These data and the finding of the present study that inhibition of Akt and p38 kinases abolished both (1) overexpression of Bcl-xL and (2) APC-induced suppression of caspase-12 cleavage argue for Bcl-xL as an essential mechanism in the suppression of ischemia-induced caspase-12 cleavage. Indeed, recent reports demonstrated that overexpression of Bcl-xL prevents endoplasmic reticulum stress and caspase-12 cleavage [33, 34].
###end p 45
###begin p 46
In conclusion, preconditioning of coronary EC with acidosis leads to activation of Akt and p38 kinases followed by overexpression of Bcl-xL and suppression of caspase-12 cleavage, which is a key mechanism in the APC-induced protection against ischemic apoptosis. Further understanding of the pH-sensing mechanism responsible for this adaptation phenomenon may lead to the discovery of new therapeutic approaches for treatment of diseases accompanied by apoptosis, e.g. tumor, neurodegenerative and ischemic diseases.
###end p 46
###begin p 47
The technical help of G. Scheibel and K. Rezny is gratefully acknowledged. This study is a part of the thesis of J.-P. Flacke submitted in fulfillment of the requirements for the degree of Doctor of Medicine at the Ruhr-University Bochum (Germany).
###end p 47
###begin p 48
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funding</bold>
Funding This study was supported by Forum Grant F591-2007 from the Ruhr-University Bochum and by Grant LA 1159/6-1 from the Deutsche Forschungsgemeinschaft.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease
###end article-title 50
###begin article-title 51
###xml 56 61 <span type="species:ncbi:9606">human</span>
Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells
###end article-title 51
###begin article-title 52
Apoptotic vascular endothelial cells become procoagulant
###end article-title 52
###begin article-title 53
###xml 47 50 <span type="species:ncbi:10116">rat</span>
A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide)
###end article-title 53
###begin article-title 54
Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury
###end article-title 54
###begin article-title 55
Preconditioning: a paradigm shift in the biology of myocardial ischemia
###end article-title 55
###begin article-title 56
Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF-kappa B, iNOS and mitochondrial K(ATP) channel
###end article-title 56
###begin article-title 57
Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest
###end article-title 57
###begin article-title 58
Moderate glucose deprivation preconditions myocardium against infarction
###end article-title 58
###begin article-title 59
Repetitive acidosis protects the ischemic heart: implications for mechanisms in preconditioned hearts
###end article-title 59
###begin article-title 60
Acidic preconditioning suppresses apoptosis and increases expression of Bcl-xL in coronary endothelial cells under simulated ischemia
###end article-title 60
###begin article-title 61
Ischemic acidosis causes apoptosis in coronary endothelial cells through activation of caspase-12
###end article-title 61
###begin article-title 62
###xml 77 82 <span type="species:ncbi:9606">human</span>
Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF
###end article-title 62
###begin article-title 63
Extracellular acidosis induces neutrophil activation by a mechanism dependent on activation of phosphatidylinositol 3-kinase/Akt and ERK pathways
###end article-title 63
###begin article-title 64
Serine/threonine protein kinases and apoptosis
###end article-title 64
###begin article-title 65
Microvascular endothelial cells from heart
###end article-title 65
###begin article-title 66
Cardiac microvascular endothelial cells express alpha-smooth muscle actin and show low NOS III activity
###end article-title 66
###begin article-title 67
"Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
###end article-title 67
###begin article-title 68
MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha
###end article-title 68
###begin article-title 69
Mechanism of Ca(2+) overload in endothelial cells exposed to simulated ischemia
###end article-title 69
###begin article-title 70
###xml 14 17 <span type="species:ncbi:10116">rat</span>
Protection of rat cardiomyocytes against simulated ischemia and reoxygenation by treatment with protein kinase C activator
###end article-title 70
###begin article-title 71
Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation
###end article-title 71
###begin article-title 72
Acidosis causes endoplasmic reticulum stress and caspase-12-mediated astrocyte death
###end article-title 72
###begin article-title 73
Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53
###end article-title 73
###begin article-title 74
###xml 30 35 <span type="species:ncbi:9606">human</span>
Acidosis-induced apoptosis in human and porcine heart
###end article-title 74
###begin article-title 75
Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury
###end article-title 75
###begin article-title 76
p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS
###end article-title 76
###begin article-title 77
Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases
###end article-title 77
###begin article-title 78
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Ischemic preconditioning of the murine liver protects through the Akt kinase pathway
###end article-title 78
###begin article-title 79
###xml 58 63 <span type="species:ncbi:9606">human</span>
Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in human keratinocytes: post-transcriptional regulation through the 3'-untranslated region
###end article-title 79
###begin article-title 80
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation
###end article-title 80
###begin article-title 81
Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families
###end article-title 81
###begin article-title 82
Suppression of endoplasmic reticulum stress-induced caspase activation and cell death by the overexpression of Bcl-xL or Bcl-2
###end article-title 82
###begin article-title 83
Translocation of Bim to the endoplasmic reticulum (ER) mediates ER stress signaling for activation of caspase-12 during ER stress-induced apoptosis
###end article-title 83
###begin title 84
Abbreviations
###end title 84
###begin p 85
Endothelial cells
###end p 85
###begin p 86
Acidic preconditioning
###end p 86
###begin p 87
Small interfering RNA
###end p 87

